Page last updated: 2024-08-21

dronabinol and Carcinoma, Lewis Lung

dronabinol has been researched along with Carcinoma, Lewis Lung in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dubinett, SM; Gardner, B; Roth, MD; Sharma, S; Stolina, M; Tashkin, DP; Zhu, LX1

Other Studies

1 other study(ies) available for dronabinol and Carcinoma, Lewis Lung

ArticleYear
Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway.
    Journal of immunology (Baltimore, Md. : 1950), 2000, Jul-01, Volume: 165, Issue:1

    Topics: Adoptive Transfer; Animals; Antibodies, Monoclonal; Antigen-Presenting Cells; Carcinoma, Lewis Lung; Cell Division; Cytokines; Dronabinol; Growth Inhibitors; Immunity, Innate; Immunosuppressive Agents; Injections, Intraperitoneal; Interleukin-10; Lymphocyte Culture Test, Mixed; Lymphocyte Subsets; Lymphocyte Transfusion; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; Neoplasm Transplantation; Receptors, Cannabinoid; Receptors, Drug; Severe Combined Immunodeficiency; T-Lymphocytes; Transforming Growth Factor beta; Tumor Cells, Cultured

2000